Advertisement
U.S. Markets open in 6 hrs 48 mins

Biosergen AB (BIOSGN.ST)

Stockholm - Stockholm Real Time Price. Currency in SEK
0.7100-0.0140 (-1.93%)
At close: 05:29PM CET
Advertisement
Show:
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Revenue
0
0
0
0
0
Cost of Revenue
226
456
280
178
0
Gross Profit
-226
-456
-280
-178
0
Operating Expense
26,868
27,179
34,524
33,900
6,226
Operating Income
-27,094
-27,635
-34,804
-34,078
-6,226
Net Non Operating Interest Income Expense
124
228
81
-240
-
Pretax Income
-26,600
-27,037
-34,048
-34,318
-6,724
Net Income Common Stockholders
-26,600
-27,037
-34,048
-34,318
-6,724
Diluted NI Available to Com Stockholders
-26,600
-27,037
-34,048
-34,318
-6,724
Basic EPS
-0.35
-0.31
-0.64
-0.72
-0.15
Diluted EPS
-0.35
-0.31
-0.64
-0.72
-0.15
Basic Average Shares
71,259
86,282
52,832
47,577
43,973
Diluted Average Shares
71,259
86,282
52,832
47,577
43,973
Total Operating Income as Reported
-26,724
-27,265
-34,129
-34,078
-6,226
Total Expenses
27,094
27,635
34,804
34,078
6,226
Net Income from Continuing & Discontinued Operation
-26,600
-27,037
-34,048
-34,318
-6,724
Normalized Income
-26,600
-27,037
-34,048
-34,318
-6,724
Interest Income
-
237
135
0
-
Interest Expense
-
9
54
240
-
Net Interest Income
124
228
81
-240
-
EBIT
-26,487
-27,028
-33,994
-34,078
-6,226
EBITDA
-26,487
-27,028
-33,994
-34,078
-6,226
Reconciled Cost of Revenue
226
456
280
178
0
Net Income from Continuing Operation Net Minority Interest
-26,600
-27,037
-34,048
-34,318
-6,724
Normalized EBITDA
-26,487
-27,028
-33,994
-34,078
-6,226
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
0
0
0
0
0